Skip to main content
Clinical Trials/NCT01235429
NCT01235429CompletedNot Applicable

Specific Aim 3: Partners in Care Randomized Controlled Trial

University of Hawaii2 sites in 1 country100 target enrollmentStarted: October 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
hemoglobin A1c

Study Overview

Brief Summary

Type 2 diabetes is common among Native Hawaiians and Pacific Peoples. Diabetes related complications decrease quality of life and can result in early morbidity. The purpose of the Partners in Care diabetes self-management educational intervention is to teach participants how to manage their diabetes to avoid or delay diabetes-related complications and how to better work with their health care team.

Detailed Description

This is a feasibility study using a randomized controlled trial (RCT) design in which 100 Native Hawaiians (NHs) and other Pacific Islanders (PPs) will be randomized to either a 3-month diabetes self-management group (DSMG; N=50) or a delayed intervention control group (CG; N=50). Participants in the DSMG will receive culturally-tailored, group diabetes self-management education delivered in a community setting by trained community peer educators. To meet this objective, we have partnered with four community-based organizations: 1) Hawai'i Maoli Association of Hawaiian Civic Clubs, 2) Ke Ola Mamo Native Hawaiian Health Care System, 3) Kokua Kalihi Valley Comprehensive Family Services, and 4) Kula No Nā Po'e Hawai'i. These four organizations provide services to a large number of Pacific People to include, but not limited to, Native Hawaiians, Samoans, Filipinos, and Chuukese. They already have intervention research experience as members of the PILI 'Ohana CBPR Project. The 3-month face-to-face intervention will be community-based and community-led by trained community peer educators from these four partnering community organizations. Individuals with a hemoglobin A1c (HbA1c; average blood sugar levels) >=8% will be recruited for the study because they represent the most at-risk for diabetes-related complications.

Over a 1-year accrual period, the community partners will recruit and enroll 100 eligible NHs and PPs (25 participants per a participating community), as well as deliver and evaluate the intervention in their respective community settings. The primary outcomes of our study are hemoglobin A1c and self-reported diabetes specific quality of life. Secondary outcomes are cholesterol levels (including HDL, LDL, total cholesterol, and triglycerides), blood pressure, body mass index, and psychosocial adaptation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-reported Native Hawaiian, Filipino, or other Pacific Islander ethnic background,
  • Adults age >=18 years,
  • English-speaking,
  • Physician-diagnosed type 2 diabetes, and
  • Baseline hemoglobin A1c >=8%

Exclusion Criteria

  • Survival less than 6 months,
  • Planning to move off island or out of state during the study period,
  • Any co-morbid condition (physical and mental disabilities) that would prevent the individual from participating in the intervention protocol (i.e., major psychiatric illness).

Outcomes

Primary Outcomes

hemoglobin A1c

Time Frame: 3 months

Hemoglobin A1c will be assessed at baseline and post intervention in the intervention and delayed intervention participants.

Secondary Outcomes

  • Quality of life(3 months)

Investigators

Sponsor
University of Hawaii
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Partners in Care Diabetes Self-management... | Clinical Trial